NasdaqGS:ANGOMedical Equipment
AngioDynamics (ANGO) EPS Loss Of US$0.26 Tests Optimistic Profit Turnaround Narratives
AngioDynamics (ANGO) has opened Q2 2026 earnings season with Q1 fiscal 2026 revenue of US$75.7 million and a basic EPS loss of US$0.26, as the market weighs those results against a current share price of US$11.44. Over recent quarters the company has reported revenue of US$67.5 million in Q1 2025, US$80.2 million in Q4 2025, and US$75.7 million in Q1 2026, while basic EPS losses moved from US$0.31 to US$0.15 and then to US$0.26. This keeps the focus on the company’s path back toward...